25
Views
14
CrossRef citations to date
0
Altmetric
Research Article

A three-year naturalistic follow-up of patients receiving clozapine: Report from India

Pages 167-171 | Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael Linden, Tabea Scheel & Klaus Rettig. (2007) Validation of the factorial structure of the Positive and Negative Syndrome Scale in use by untrained psychiatrists in routine care. International Journal of Psychiatry in Clinical Practice 11:1, pages 53-60.
Read now

Articles from other publishers (13)

Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, Kohei Kitagawa, Masafumi Kodama & Hiroyoshi Takeuchi. (2022) Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study. International Clinical Psychopharmacology 38:2, pages 96-101.
Crossref
Shrikant Srivastava & Anil K Agarwal. (2022) A Naturalistic Study of Obsessive-compulsive Disorder: A Retrospective Chart Review. Indian Journal of Private Psychiatry 16:2, pages 87-90.
Crossref
Shrikant Srivastava & Anil K Agarwal. (2022) A Naturalistic Study of Obsessive-compulsive Disorder: A Retrospective Chart Review. Indian Journal of Private Psychiatry 16:2, pages 87-90.
Crossref
Deeba Nazir, Zaid Ahmad Wani, Fahd Bukhari, Shabir Ahmad Dar & Yuman Kawoosa. (2021) Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India. Middle East Current Psychiatry 28:1.
Crossref
Tom Varghese M, KS Jyothi, KS Shaji & Lekshmi Rita Venugopal. (2020) Delaying clozapine: how long is too long?. General Psychiatry 33:2, pages e100172.
Crossref
Jentien M Vermeulen, Geeske van Rooijen, Marita P J van de Kerkhof, Arjen L Sutterland, Christoph U Correll & Lieuwe de Haan. (2019) Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years. Schizophrenia Bulletin 45:2, pages 315-329.
Crossref
Sandeep Grover, Subho Chakrabarti, Nandita Hazari & Ajit Avasthi. (2017) Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study. Psychiatry Research 249, pages 349-353.
Crossref
Ayala Shirazi, Brendon Stubbs, Lucia Gomez, Susan Moore, Fiona Gaughran, Robert Flanagan, James MacCabe & John Lally. (2016) Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 17:6, pages 863.
Crossref
Parmanand Kulhara, Sandeep Grover & Natasha Kate. 2015. Developments in Psychiatry in India. Developments in Psychiatry in India 173 200 .
Alakananda Dutt, Sandeep Grover, Subho Chakrabarti, Parmanand Kulhara, Ajit Avasthi, Debasish Basu & Partha Pratim Das. (2010) Effectiveness of clozapine: A study from North India. Asian Journal of Psychiatry 3:1, pages 16-19.
Crossref
Ajit Avasthi, Munish Aggarwal, Sandeep Grover & Mohd KhalidRasheed Khan. (2010) Research on antipsychotics in India. Indian Journal of Psychiatry 52:7, pages 317.
Crossref
Sandeep Grover, Alakananda Dutt & Ajit Avasthi. (2010) Indian research: Focus on clozapine. Indian Journal of Psychiatry 52:2, pages 168.
Crossref
. (2003) Current Awareness in Human Psychopharmacology. Human Psychopharmacology: Clinical and Experimental 18:2, pages 153-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.